European Commission approves Pharming's Joenja for APDS treatment in the EU

Caliway Biopharmaceuticals receives US FDA IND clearance for second global Phase 3 study of CBL-514

AbbVie's MAVIRET receives positive opinion from European regulator

Enhertu recommended for EU approval in previously treated HER2 positive metastatic solid tumours

Allergan Aesthetics reports positive CHMP opinion recommending approval of Boey (trenibotulinumtoxinE)

Bayer's KERENDIA receives FDA priority review for type 1 diabetes and kidney disease treatment

Upsher-Smith launches generic Cyclosporine Ophthalmic Emulsion 0.05%

BioMarin Pharmaceutical meets primary endpoint in Phase 3 study of VOXZOGO in children with hypochondroplasia

Medtronic plans to SPR Therapeutics for USD650m to expand pain management portfolio

Implantica submits final FDA response for RefluxStop PMA application

FDA approves MEKanistic Therapeutics' IND for MTX-531

Matter Bio submits first IND application for Lm-LLO-TT

Hansa Biopharma signs EUR115m IDEFIRIX licensing deal with SERB

Lupin receives tentative FDA approval for Revefenacin Inhalation Solution

Artivion completes acquisition of Endospan following FDA approval of NEXUS Aortic Arch System